|
Company
Roster
|
Total
Insiders : |
45 |
|
|
Total
Direct Shares :
|
23,623,653 |
|
Total
Indirect Shares :
|
135,347,239 |
|
%
Held by Insiders:
|
16.18% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Papadopoulos Stelios |
|
2024-03-14 |
978,388 |
2014-12-12 |
0 |
Aker Christopher Ray |
Sr. VP & General Counsel |
2024-01-18 |
10,056 |
2019-02-05 |
0 |
Calsada Crispina |
Chief Financial Officer |
2024-01-18 |
5,782 |
2024-01-12 |
0 |
Hagan Joseph P |
Chief Executive Officer, Director |
2024-01-18 |
57,112 |
2020-12-04 |
225,674 |
Drygin Denis |
Chief Scientific Officer |
2022-03-01 |
100,000 |
2022-02-04 |
0 |
Nea 16 Gp, Llc |
10% Owner |
2020-12-04 |
6,451,056 |
|
0 |
Sarissa Capital Master Fund Ii Lp |
10% Owner |
2020-04-01 |
76,356 |
|
0 |
Chevallard Daniel R. |
Chief Financial Officer |
2019-07-01 |
77,870 |
|
0 |
Witz Pascale |
Director |
2019-05-07 |
37,849 |
2017-12-04 |
0 |
Walker Paul Edward |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
Chang Carmen |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
Behbahani Ali |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
Wright Timothy Michael |
Chief R & D Officer |
2019-02-05 |
62,893 |
2017-07-25 |
0 |
Collier Kathryn J |
Director |
2018-11-16 |
27,596 |
2018-04-14 |
0 |
Baltimore David |
Director |
2018-11-12 |
44,131 |
2017-12-04 |
0 |
Rosen Hugh |
Director |
2018-11-12 |
22,756 |
2017-12-04 |
0 |
Foletta Mark G |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Alnylam Pharmaceuticals, Inc. |
10% Owner |
2016-02-23 |
4,896,716 |
2012-10-10 |
0 |
Rastetter William H |
Director |
2015-07-20 |
0 |
2020-02-03 |
390,584 |
Isis Pharmaceuticals Inc |
10% Owner |
2015-07-17 |
5,173,172 |
2012-10-10 |
0 |
Xanthopoulos Kleanthis G |
President and CEO, Director |
2015-04-21 |
3,705 |
2015-04-21 |
80,216 |
Carter Bruce L A |
Director |
2015-04-13 |
0 |
2015-04-13 |
0 |
Gibson Neil W |
Chief Scientific Officer |
2015-01-28 |
0 |
2013-02-04 |
0 |
Parshall B Lynne |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
Crooke Stanley T |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Maraganore John |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Greene Barry E |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Deeg Mark Albert |
|
|
0 |
|
0 |
Florence Anthony A. Jr. |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Makhzoumi Mohamad |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Sonsini Peter W. |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Baskett Forest |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Szekeres David Leslie |
|
|
0 |
|
0 |
Puttagunta Chetan |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
Sakoda Jon |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
Mott David M |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
Sanofi-Aventis |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
Astrazeneca Ab |
10% Owner |
|
0 |
2014-11-12 |
4,250,000 |
Simeonidis Simos |
Director |
|
0 |
2019-06-06 |
1,851,851 |
Viswanathan Ravi |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
Barris Peter J |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
Makower Joshua |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Menzel Garry E |
Officer |
|
0 |
2012-10-04 |
111,842 |
Sarissa Capital Offshore Master Fund Lp |
10% Owner |
|
0 |
2019-05-07 |
1,851,851 |
Sandell Scott D |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
|